Literature DB >> 23605058

Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry.

Marco D'Arienzo1, Luca Filippi, Paola Chiaramida, Laura Chiacchiararelli, Roberto Cianni, Rita Salvatori, Francesco Scopinaro, Oreste Bagni.   

Abstract

A 54-year-old woman with metastatic colorectal carcinoma underwent liver radioembolization with (90)Y resin microspheres. Microsphere biodistribution was assessed 2 h after the treatment through a 20-min long (90)Y PET scan. Isodose map and lesion dose-volume histogram (DVH) were then evaluated using a MATLAB-based code. Response to therapy was assessed performing a (18)F-FDG PET 6 months after the treatment. At (90)Y PET the patient showed a well-defined horseshoe-shaped hepatic lesion with hot margins and a cold core. The lesion presented a heterogeneous DVH with a hot margin receiving an average radiation dose as high as 287 Gy and a cold area receiving an average radiation dose of 70 Gy approximately. Six months after the treatment the patient reported a complete remission of tumour areas which received a high radiation dose, while progression of metastases was observed in the area that presented scarce microsphere localization at (90)Y PET. According to our experience, the use of (90)Y PET voxel dosimetry may provide a useful tool to assess possible correlations between microsphere biodistribution and clinical outcome of the treatment. In agreement with current literature findings, an average radiation dose greater than approximately 100 Gy may be required to sterilize liver metastases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23605058     DOI: 10.1007/s12149-013-0726-4

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  12 in total

1.  Sequential Use of (90)Y Microspheres Radioembolization and (177)Lu-Dotatate in Pluri-Metastatic Neuroendocrine Tumors: A Case Report.

Authors:  Luca Filippi; Alida Ciorra; Barbara Sardella; Orazio Schillaci; Oreste Bagni
Journal:  Nucl Med Mol Imaging       Date:  2014-09-06

2.  A Comparison of Techniques for (90)Y PET/CT Image-Based Dosimetry Following Radioembolization with Resin Microspheres.

Authors:  Alexander S Pasciak; Austin C Bourgeois; Yong C Bradley
Journal:  Front Oncol       Date:  2014-05-22       Impact factor: 6.244

3.  Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization.

Authors:  Marco D'Arienzo; Maria Pimpinella; Marco Capogni; Vanessa De Coste; Luca Filippi; Emiliano Spezi; Nick Patterson; Francesca Mariotti; Paolo Ferrari; Paola Chiaramida; Michael Tapner; Alexander Fischer; Timo Paulus; Roberto Pani; Giuseppe Iaccarino; Marco D'Andrea; Lidia Strigari; Oreste Bagni
Journal:  EJNMMI Res       Date:  2017-11-28       Impact factor: 3.138

4.  Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis.

Authors:  Kathy P Willowson; Aimee R Hayes; David L H Chan; Michael Tapner; Elizabeth J Bernard; Richard Maher; Nick Pavlakis; Stephen J Clarke; Dale L Bailey
Journal:  EJNMMI Res       Date:  2017-05-23       Impact factor: 3.138

5.  Relationship of radiation dose to efficacy of radioembolization of liver metastasis from breast cancer.

Authors:  Fourat Ridouani; Mohamed M Soliman; Ryan W England; Meier Hsu; Chaya S Moskowitz; Raphael Doustaly; Constantinos T Sofocleous; F Edward Boas; Hooman Yarmohammadi; Amy R Deipolyi
Journal:  Eur J Radiol       Date:  2021-01-12       Impact factor: 3.528

6.  Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneity.

Authors:  Jonas Högberg; Magnus Rizell; Ragnar Hultborn; Johanna Svensson; Olof Henrikson; Johan Mölne; Peter Gjertsson; Peter Bernhardt
Journal:  EJNMMI Phys       Date:  2015-04-25

Review 7.  Radioembolization and the Dynamic Role of (90)Y PET/CT.

Authors:  Alexander S Pasciak; Austin C Bourgeois; J Mark McKinney; Ted T Chang; Dustin R Osborne; Shelley N Acuff; Yong C Bradley
Journal:  Front Oncol       Date:  2014-02-27       Impact factor: 6.244

Review 8.  Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective.

Authors:  Marta Cremonesi; Carlo Chiesa; Lidia Strigari; Mahila Ferrari; Francesca Botta; Francesco Guerriero; Concetta De Cicco; Guido Bonomo; Franco Orsi; Lisa Bodei; Amalia Di Dia; Chiara Maria Grana; Roberto Orecchia
Journal:  Front Oncol       Date:  2014-08-19       Impact factor: 6.244

9.  Computational simulation of the predicted dosimetric impact of adjuvant yttrium-90 PET/CT-guided percutaneous ablation following radioembolization.

Authors:  Alexander S Pasciak; Abigail Lin; Christos Georgiades; Laura K Findeiss; Shannon Kauffman; Yong C Bradley
Journal:  EJNMMI Res       Date:  2016-12-12       Impact factor: 3.138

10.  Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study.

Authors:  Nichole M Maughan; Mootaz Eldib; David Faul; Maurizio Conti; Mattijs Elschot; Karin Knešaurek; Francesca Leek; David Townsend; Frank P DiFilippo; Kimberly Jackson; Stephan G Nekolla; Mathias Lukas; Michael Tapner; Parag J Parikh; Richard Laforest
Journal:  EJNMMI Phys       Date:  2018-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.